The GM1 Gangliosidosis Treatment Market size was valued at USD 185 Million in 2025 and is expected to grow at a CAGR of 14.5% from 2025 to 2034, reaching USD 625.8 Million by 2034.
The GM1 Gangliosidosis Treatment Market is an emerging rare-disease therapeutics segment focused on developing therapies for GM1 gangliosidosis, a genetic lysosomal storage disorder caused by...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek